文献速递慢阻肺睡眠呼吸障碍呼吸危重症与机械通气

执行摘要:最佳无创通气医保准入促进:美国胸科医师学会等多学会技术专家小组报告

Executive Summary: Optimal NIV Medicare Access Promotion: A Technical Expert Panel Report From the American College of Chest Physicians, the American Association for Respiratory Care, the American Academy of Sleep Medicine, and the American Thoracic Society.
PubMed 文献 · Chest · 2021-07-30

美国胸科医师学会联合美国呼吸治疗学会、美国睡眠医学会和美国胸科学会组织专家小组,针对胸廓限制性疾病、慢阻肺、低通气综合征、阻塞性睡眠呼吸暂停和中枢性睡眠呼吸暂停五个领域,识别当前最佳无创通气治疗的障碍,汇总支持政策更新的科学证据,并提出修订国家覆盖确定的建议,旨在实现「正确设备、正确患者、正确时机」。

要点

  • 现行无创通气国家覆盖确定制定于1998年,已与新的研究证据、指南和共识冲突。
  • 专家小组聚焦胸廓限制性疾病、慢阻肺、低通气综合征、OSA和中枢性睡眠呼吸暂停五个领域。
  • 建议旨在为修订国家覆盖确定提供依据,确保患者获得最佳健康结局。

核心结论

  • 现行无创通气国家覆盖确定需更新,以纳入新证据和指南,优化五类疾病患者的治疗。

主要发现

  • 专家小组识别了当前最佳护理的障碍,并汇总了支持政策变更的科学证据。

临床怎么用

  • 建议将用于修订现行国家覆盖确定,指导无创通气在五类疾病中的合理应用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The current national coverage determinations (NCDs) for noninvasive ventilation for patients with thoracic restrictive disorders, COPD, and hypoventilation syndromes were formulated in 1998. New original research, updated formal practice guidelines, and current consensus expert opinion have accrued that are in conflict with the existing NCDs. Some inconsistencies in the NCDs have been noted, and the diagnostic and therapeutic technology has also advanced in the last quarter century. Thus, these and related NCDs relevant to bilevel positive airway pressure for the treatment of OSA and central sleep apnea need to be updated to ensure the optimal health of patients with these disorders. To that end, the American College of Chest Physicians organized a multisociety (American Thoracic Society, American Academy of Sleep Medicine, and American Association for Respiratory Care) effort to engage experts in the field to: (1) identify current barriers to optimal care; (2) highlight compelling scientific evidence that would justify changes from current policies incorporating best evidence and practice; and (3) propose suggestions that would form the basis for a revised NCD in each of these 5 areas (thoracic restrictive disorders, COPD, hypoventilation syndromes, OSA, and central sleep apnea). The expert panel met during a 2-day virtual summit in October 2020 and subsequently crafted written documents designed to achieve provision of "the right device to the right patient at the right time." These documents have been endorsed by the participating societies following peer review and publication in CHEST and will be used to inform efforts to revise the current NCDs.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Gay PC, Owens RL. Executive Summary: Optimal NIV Medicare Access Promotion: A Technical Expert Panel Report From the American College of Chest Physicians, the American Association for Respiratory Care, the American Academy of Sleep Medicine, and the American Thoracic Society. Chest. 2021. PMID: 34339685. doi:10.1016/j.chest.2021.05.074

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。